Key Highlights
- ARK Invest acquired 233,482 shares of Rocket Lab valued at approximately $16.4 million on October 1.
- The investment firm divested 20,805 Palantir shares valued at roughly $4 million during the same trading session.
- Additional purchases included stakes in BWX Technologies, Intellia Therapeutics, and Veracyte.
- The fund reduced holdings in Alphabet and exited a minor Zillow position.
- Analyst consensus rates Rocket Lab as a Strong Buy with 56% potential upside, while Palantir earns a Moderate Buy rating with 6% projected gains.
On Thursday, October 1, Cathie Wood’s ARK Invest executed multiple portfolio adjustments across its exchange-traded funds. The firm’s mandatory daily trade disclosures revealed significant acquisitions in select aerospace and technology stocks alongside strategic divestitures.
The investment management company purchased 233,482 shares of Rocket Lab distributed across three of its actively managed funds. This transaction totaled approximately $16.4 million in value.
Simultaneously, ARK divested 20,805 shares of Palantir Technologies. This sale generated approximately $4 million in proceeds.
Year-to-date performance shows Rocket Lab shares have climbed roughly 1%. Meanwhile, Palantir stock has appreciated approximately 7% during the same timeframe.
Rocket Lab Expands Commercial Launch Backlog and Revenue
Rocket Lab has secured its most substantial commercial contract to date for its Electron launch vehicle. The agreement encompasses 20 additional launches for Synspective, a Japanese satellite operator.
This expansion brings Synspective’s total mission manifest with Rocket Lab to 47 launches. The growing backlog provides enhanced revenue visibility for the aerospace company.
Rocket Lab posted second-quarter revenue totaling $234 million. This represents a 62% year-over-year increase compared to the prior-year quarter.
Development continues on the company’s medium-lift Neutron rocket. Additionally, Rocket Lab is advancing its proposed acquisition of satellite communications provider Iridium Communications.
Wall Street sentiment on Rocket Lab remains predominantly bullish. Among 16 analysts tracking the stock, 14 maintain Buy ratings while 2 assign Hold ratings.
Consensus price targets for Rocket Lab average $110.07. This target implies potential upside of 56% from present trading levels.
Palantir Demonstrates Strong Commercial Revenue Acceleration
Palantir delivered second-quarter revenue of $1.94 billion, marking a 93% surge versus the year-ago period. The company’s U.S. commercial revenue segment expanded 149% to reach $764 million.
During the quarter, Palantir executed 220 contracts valued at a minimum of $1 million each. This metric demonstrates sustained enterprise adoption of its data analytics platforms.
The software company has announced several strategic collaborations. Recent partnerships include agreements with Nebius, PwC, and Armada.
Analyst sentiment toward Palantir remains favorable, though comparatively more measured than Rocket Lab. Of 22 analysts covering the stock, 16 recommend Buy ratings, 4 suggest Hold positions, and 2 advise Sell.
Average price targets for Palantir stand at $201.74. This consensus figure represents approximately 6% upside from current market valuations.
ARK Invest executed additional portfolio transactions on the same trading day. The firm acquired shares of BWX Technologies, which manufactures nuclear components, totaling approximately $13.6 million.
ARK also increased its stake in Intellia Therapeutics, a biotechnology firm focused on CRISPR gene-editing technology. This purchase amounted to nearly $5 million.
The fund bought shares of Veracyte, which develops genomic diagnostic tests, valued at more than $7.3 million.
Among divestments, ARK trimmed its Alphabet holdings by selling 101 shares. The firm also liquidated a minimal Zillow position valued at approximately $20,000.
These transactions represent standard portfolio rebalancing activities that ARK discloses daily for transparency across all its exchange-traded fund offerings.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
